SCHEMBL3914754

SCHEMBL3914754

COC(=O)c1cc(Br)c(Oc2ccc(N)cc2)c(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
PARP10 Q53GL7 1/20 0.44
NOTUM Q6P988 1/20 0.43
THRA P10827 2/20 0.43
THRB P10828 2/20 0.43
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
MAPT P10636 5/20 0.41
POLB P06746 2/20 0.41
GAA P10253 4/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ATM Q13315 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPK1 P28482 1/20 0.40
TPMT P51580 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6821909 0.84 USP2 (0.54) USP2KDM4EALDH1A1NOTUMTHRA
SCHEMBL10078186 0.81 USP2 (0.56) USP2KDM4EALDH1A1PARP10CA1
SCHEMBL5000622 0.81 USP2 (0.60) USP2KDM4EALDH1A1PARP10CA1
SCHEMBL3914980 0.80 POLB (0.52) KDM4EALDH1A1MAPTPOLBGAA
SCHEMBL3137803 0.80 KDM4E (0.51) KDM4EALDH1A1THRATHRBMAPT
SCHEMBL4242980 0.79 PARP10 (0.63) KDM4EALDH1A1PARP10CA1CA2
SCHEMBL3133337 0.77 SMN1; SMN2 (0.43) KDM4EALDH1A1THRATHRBHPGD
SCHEMBL4527269 0.77 THRA (0.48) KDM4EALDH1A1THRATHRBCA1
SCHEMBL3925371 0.77 CYP19A1 (0.51) KDM4EALDH1A1PARP10THRATHRB
SCHEMBL3131477 0.76 THRB (0.48) ALDH1A1THRATHRBMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
EP-2035377-A1 INDOLE DERIVATIVES AND THEIR USE AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2009-03-18 EP disclosed
WO-2007134864-A1 INDOLE DERIVATIVES AND THEIR USE AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2007-11-29 WO disclosed
WO-2007134864-A1 INDOLE DERIVATIVES AND THEIR USE AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2007-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands TSHR, TRHR, THRA USP2 3522/4885KDM4E 1169/4885ALDH1A1 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.